Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality
Ping Liu, Thomas J Lanza, Marc Chioda, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists
Shuwen He, Peter H Dobbelaar, Jian Liu, et al.
Cell Chemical Biology
|
October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
International Journal of Biological Sciences
|
February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes
Liwen Zhang, Timothy McCabe, Jon H Condra, et al.
Journal of Lipid Research
|
October 25, 2011
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia
Wu Yin, Ester Carballo-Jane, David G McLaren, et al.
Nature
|
April 17, 2024
Environmental drivers of increased ecosystem respiration in a warming tundra
S L Maes, J Dietrich, G Midolo, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality
Ping Liu, Thomas J Lanza, Marc Chioda, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 20, 2010
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists
Shuwen He, Peter H Dobbelaar, Jian Liu, et al.
Cell Chemical Biology
|
October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
International Journal of Biological Sciences
|
February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes
Liwen Zhang, Timothy McCabe, Jon H Condra, et al.
Journal of Lipid Research
|
October 25, 2011
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia
Wu Yin, Ester Carballo-Jane, David G McLaren, et al.
Nature
|
April 17, 2024
Environmental drivers of increased ecosystem respiration in a warming tundra
S L Maes, J Dietrich, G Midolo, et al.
Page
of 14